智飞生物(300122.SZ)：带状疱疹mRNA疫苗获临床试验批准

Core Viewpoint - The company Zhifei Biological Products Co., Ltd. has received approval from the National Medical Products Administration for clinical trials of its mRNA vaccine aimed at preventing shingles [1] Group 1 - The subsidiary Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. is responsible for the development of the shingles mRNA vaccine [1] - The approval allows the company to proceed with clinical trials for the vaccine [1]